San Francisco's goBalto raised $12 million to push its clinical trial software, designed to expedite study startup.
Study startup specialist goBalto is preparing to up its game in Asia. The San Francisco, CA-based software developer outlined the strategy after raising $12 million from new backers, including Japan's Mitsui Global Investment.
San Francisco clinical trial software outfit goBalto has made its first big international push, opening outposts in Singapore and the U.K.
GoBalto has introduced version 2.0 of Tracker, its software-as-a-service platform designed to streamline clinical trial startup.
By Nick Paul Taylor The Fenwick & West analysis of life science venture capital investment in 2012 is a downbeat read. Equity investments dropped 19% and the number of first round financings fell...
Behind the huge and scary numbers that accompany the costs of drug development, there are various holes and dysfunctional practices in the process of bringing a new drug to market.
INC Research has signed on to use goBalto's web-based software to boost the process of getting clinical trials up and running, providing the Bay Area startup with what appears to be one of its biggest customer wins yet for the tech.
Fresh off raising $12 million in Series B financing, goBalto has lured a major CRO with its cloud-based clinical development platform, signing a deal with INC Research.
With cloud-based software to get clinical trials off the ground faster, goBalto has reeled in $12 million in a new round of financing with backing from wireless giant Qualcomm's Life Fund and others. Its new investor hopes goBalto's platform can address the steep rise in the cost of developing new therapies.
San Francisco's goBalto has pulled in $12 million in Series B financing to advance its cloud-based clinical development platform, which allows sponsors and CROs to monitor and collaborate on study results.